Overview of Glioblastoma

Abstract

Glioblastoma multiforme (GBM), a rapidly developing and highly aggressive brain tumor, accounts for more than 49 percent of all primary malignant brain tumors . Through the extensive research of medical professionals, the scientific community has gained a deeper understanding of GBM, and thus discovered common symptoms, medical treatments, and distinct therapies to attempt to treat the patient. Treatment for GBM is challenging due to the disease's innate resistance to conventional therapy and its propensity for invasive behavior; as a result, more effective neuro-oncological and neurosurgical therapies are required .  Despite improvements in our understanding of GBM, its inherent invasiveness and resistance to standard treatments makes it extremely difficult to find a cure. It is important to educate healthcare and local communities on the importance of the severity of glioblastomas to inculcate the urgency in patients to seek medical attention once neurological symptoms are detected. In doing so, the patient’s overall physical and emotional well-being may be exceptionally improved. As experts continue to advance their medical care for those suffering from GBM, exposing its severity to local communities yields the patient a better prognosis.